Navigation Links
Nerve Damage Can Be Prevented By Xenon Administration During Surgery

Brain damage, a potential post-operative complication following coronary artery bypass grafting (CABG) could be prevented by provision of xenon gas, a new study has found. // The results of this first successful clinical trial can be found in Anesthesiology journal.

The researchers successfully administered xenon gas safely to a group of 12 patients undergoing CABG. This revolutionary technique could eventually pave way for development of new treatments for diseases associated with nerve damage such as stroke, spinal cord and brain injury.

Previous studies had established the effectiveness of xenon in neuroprotection. It inhibits the cascade of events that occur during stroke or brain/spinal cord injury. These events result in irreversible damage to the brain. Xenon, a neuroprotectant was found to inhibit activity of the glutamate receptor that resulted in nerve death. Prof. Nick Franks accidentally discovered this potential of xenon while he was involved in the identification of specific molecular targets related to anesthetic action.

Following demonstration of the feasibility of xenon administration to at risk individuals for development of brain damage, the researchers are keen about initiating a clinical trial to test the effectiveness of xenon in a large group of patients. Through current medical treatments, it is possible to prevent mortality associated with nerve damage; nothing can be done to inhibit nerve damage that causes long-term disability.

Xenon is a naturally occurring gas and no instances of toxicity has so far been reported, that makes it an ideal candidate for use as a neuroprotectant.


'"/>




Page: 1

Related medicine news :

1. Epilepsy Drug Helps Diabetic Nerve Damage
2. World’s First Nerve Stem Cells Produced
3. Children With Epilepsy Can Be Treated With Nerve Stimulation
4. FDA Approved Nerve-Stimulation Therapy Now Available In New York
5. Doctors Finish Mother-To-Son Nerve Surgery
6. Stem Cells From Hair Follicle To Repair Nerve Damage
7. Nerve regeneration for Spinal cord injuries
8. Novel Protein, Staufen2 Important In Maintenance Of Nerve Synapses
9. Dividing Nerve Cells Could Trigger Alzheimers Disease
10. Protein Found to Be Essential For Maintaining Nerve Health
11. Nerve Stimulator for Depression Though Not Effective Was Given Approval
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/20/2017)... ... January 20, 2017 , ... ... to enhance people’s everyday lives, recently attended the January ECRM Trade Show in ... Science is known for its large range of supplements that keep the body ...
(Date:1/20/2017)... ... January 20, 2017 , ... Michael and Betsy Brauser celebrated 5 years of ... the clinical trial has been life-saving as she has been on the trial ... Brauser was diagnosed with ovarian cancer in 2009. She underwent standard chemotherapy but a ...
(Date:1/20/2017)... ... 20, 2017 , ... Vitamin Well has launched two new ... have been produced in collaboration with Zlatan Ibrahimovic and have been developed to ... a successful launch in Sweden last year, the next generation sports drinks VW+001 ...
(Date:1/20/2017)... ... January 20, 2017 , ... “The Angel”: a heartwarming and earnest ... for each of his children. “The Angel” is the creation of published author, Marjorie ... York City, and impassioned writer. , When asked of her new book, Marjorie says, ...
(Date:1/20/2017)... ... ... You”: a fine examination of how God handles sin, including how to let go ... Miller, who, for over ten long years has been waiting to release this powerful insight ... he has been serving the Lord for over twenty years, and he has been preaching ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 19, 2017 James ... & Haematology, 2016;12(Suppl 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ... ... Published recently in a supplement to European ... touchONCOLOGY, an article by James Gilbart ...
(Date:1/19/2017)... LEXINGTON, Massachusetts , January 19, 2017 ... SHPG ) announced that the U.S. Food and Drug ... resubmission of a New Drug Application (NDA) for SHP465, ... being evaluated as a potential once-daily treatment for Attention-Deficit/Hyperactivity ... decision on or around June 20, 2017, the designated ...
(Date:1/19/2017)... LONDON , January 19, 2017 ... New Therapeutic Option to Address Motor Symptoms and ... ...      (Logo: http://photos.prnewswire.com/prnh/20151014/276718LOGO) ... Fabrizio Stocchi , European Neurological Review,2016;11(Suppl. 2): 2-15, ...
Breaking Medicine Technology: